This compound is a stereochemically defined active pharmaceutical ingredient intermediate impurity associated with the manufacture of aliskiren hemifumarate. It contains an amine, an aromatic ring, an ester, and multiple ether functional groups, with a molecular weight of approximately 435.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Rebamipide
pharmaceutical raw material
Colextran
pharmaceutical raw material
Pegademase bovine
pharmaceutical raw material
Ractopamine hydrochloride
pharmaceutical raw material
[(1S,3S)-3-[[4-Methoxy-3-(3-methoxypropoxy)phenyl]methyl]-4-methyl-1-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]pentyl]carbamic acid tert-butyl ester
pharmaceutical intermediate
(3S,5S)-5-[(1S,3S)-1-amino-3-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-4-methylpentyl]-3-propan-2-yloxolan-2-one
KCUIZDBXYKOADQ-FKEBYFGASA-N
CC(C)[C@@H]1C[C@H](OC1=O)[C@H](C[C@H](CC2=CC(=C(C=C2)OC)OCCCOC)C(C)C)N
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.